Innate and Adaptive Immunity in Calcific Aortic Valve Disease
Open accessThe DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.
Abstract
Calcific aortic valve disease (CAVD) is the most common heart valve disorder. CAVD is a chronic process characterized by a pathologic mineralization of valve leaflets. Ectopic mineralization of the aortic valve involves complex relationships with immunity. Studies have highlighted that both innate and adaptive immunity play a role in the development of CAVD. In this regard, accumulating evidence indicates that fibrocalcific remodelling of the aortic valve is associated with activation of the NF-κ B pathway. The expression of TNF-α and IL-6 is increased in human mineralized aortic valves and promotes an osteogenic program as well as the mineralization of valve interstitial cells (VICs), the main cellular component of the aortic valve. Different factors, including oxidized lipid species, activate the innate immune response through the Toll-like receptors. Moreover, VICs express 5-lipoxygenase and therefore produce leukotrienes, which may amplify the inflammatory response in the aortic valve. More recently, studies have emphasized that an adaptive immune response is triggered during CAVD. Herein, we are reviewing the link between the immune response and the development of CAVD and we have tried, whenever possible, to keep a translational approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149 · cited 1×
“By using a wholegenome transcriptomic approach El Husseini et al. identified that, among the family of cytokines that signal through gp130, IL-6 is highly expressed in mineralized aortic valves [23].”
MethodOsteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,012
Hsu, H., Shu, H.-B., Pan, M.-G., & Goeddel, D. V. (1996) · Cell · doi:10.1016/s0092-8674(00)80984-8 · Cited by 1,998
Mutations in NOTCH1 cause aortic valve disease
Garg, V., Muth, A. N., Ransom, J. F., Schluterman, M. K., Barnes, R., King, I. N., Grossfeld, P. D., & Srivastava, D. (2005) · Nature · doi:10.1038/nature03940 · Cited by 1,509
Otto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., & O'Brien, K. D. (1994) · Circulation · doi:10.1161/01.cir.90.2.844 · Cited by 1,315
RANKL–RANK signaling in osteoclastogenesis and bone disease
Wada, T., Nakashima, T., Hiroshi, N., & Penninger, J. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.11.007 · Cited by 1,212
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
Beg, A. A., Finco, T. S., Nantermet, P. V., & Baldwin, A. S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3301 · Cited by 1,027
Genetic Associations with Valvular Calcification and Aortic Stenosis
Thanassoulis, G., Campbell, C. Y., Owens, D. S., Smith, J. G., Smith, A. V., Peloso, G. M., Kerr, K. F., Pechlivanis, S., Budoff, M. J., Harris, T. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109034 · Cited by 1,008
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.
Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L., & Hansson, G. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3893 · Cited by 943
Rajamannan, N. M., Evans, F. J., Aikawa, E., Grande-Allen, K. J., Demer, L. L., Heistad, D. D., Simmons, C. A., Masters, K. S., Mathieu, P., O'Brien, K. D., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.006767 · Cited by 842 · cited 1×
“As such, there is a continuum fromaortic valve sclerosis to severe aortic stenosis with a common underlying process: ectopic mineralization of the aortic valve [2].”
BackgroundSelf-citationMiller, Y. I., Choi, S.-H., Wiesner, P., Fang, L., Harkewicz, R., Hartvigsen, K., Boullier, A., Gonen, A., Diehl, C. J., Que, X., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.223875 · Cited by 646
Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
Kamstrup, P. R., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.038 · Cited by 595 · cited 1×
“Using a Mendelian randomization study design two other independent studies have since then corroborated the positive association between Lp(a) and CAVD [79, 80].”
ResultTRANCE, a TNF Family Member, Activates Akt/PKB through a Signaling Complex Involving TRAF6 and c-Src
Wong, B. R., Besser, D., Kim, N., Arron, J. R., Vologodskaia, M., Hanafusa, H., & Choi, Y. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80232-4 · Cited by 592
The nuclear factor- B-interleukin-6 signalling pathway mediating vascular inflammation
Brasier, A. R. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq076 · Cited by 586
O’Brien, K. D., Reichenbach, D. D., Marcovina, S. M., Kuusisto, J., Alpers, C. E., & Otto, C. M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.4.523 · Cited by 560
Visceral Obesity: The Link Among Inflammation, Hypertension, and Cardiovascular Disease
Mathieu, P., Poirier, P., Pibarot, P., Lemieux, I., & Després, J.-P. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.110320 · Cited by 490
Self-citationThe TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor
Wong, B. R., Josien, R., Lee, S. Y., Vologodskaia, M., Steinman, R. M., & Choi, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28355 · Cited by 458
Ubiquitin-mediated activation of TAK1 and IKK
Adhikari, A., Xu, M., & Chen, Z. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210413 · Cited by 457
Obesity, Inflammation, and Cardiovascular Risk
Mathieu, P., Lemieux, I., & Després, J.-P. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.311 · Cited by 419
Self-citationPresence of Oxidized Low Density Lipoprotein in Nonrheumatic Stenotic Aortic Valves
Olsson, M., Thyberg, J., & Nilsson, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1218 · Cited by 417
Lum, L., Wong, B. R., Josien, R., Becherer, J. D., Erdjument-Bromage, H., Schlöndorff, J., Tempst, P., Choi, Y., & Blobel, C. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13613 · Cited by 410
Computational Drug Repositioning: From Data to Therapeutics
Hurle, M. R., Yang, L., Xie, Q., Rajpal, D. K., Sanseau, P., & Agarwal, P. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.1 · Cited by 373
Miller, J. D., Chu, Y., Brooks, R. M., Richenbacher, W. E., Peña-Silva, R., & Heistad, D. D. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.043 · Cited by 357
Vascular calcification and bone disease: the calcification paradox
Persy, V., & D’Haese, P. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.07.001 · Cited by 332
Phosphorylation of RelA/p65 on Serine 536 Defines an IκBα-independent NF-κB Pathway
Sasaki, C. Y., Barberi, T. J., Ghosh, P., & Longo, D. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504943200 · Cited by 330
O’Brien, K. D., Shavelle, D. M., Caulfield, M. T., McDonald, T. O., Olin-Lewis, K., Otto, C. M., & Probstfield, J. L. (2002) · Circulation · doi:10.1161/01.cir.0000035655.45453.d2 · Cited by 318
Arsenault, B. J., Boekholdt, S. M., Dubé, M.-P., Rhéaume, É., Wareham, N. J., Khaw, K.-T., Sandhu, M. S., & Tardif, J.-C. (2014) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000400 · Cited by 315
Aikawa, E., Aikawa, M., Libby, P., Figueiredo, J.-L., Rusanescu, G., Iwamoto, Y., Fukuda, D., Kohler, R. H., Shi, G.-P., Jaffer, F. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.827972 · Cited by 310
Al-Aly, Z., Shao, J.-S., Lai, C.-F., Huang, E., Cai, J., Behrmann, A., Cheng, S.-L., & Towler, D. A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.153668 · Cited by 307
Xiao, G., Fong, A., & Sun, S.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401428200 · Cited by 295
Bertazzo, S., Gentleman, E., Cloyd, K. L., Chester, A. H., Yacoub, M. H., & Stevens, M. M. (2013) · Nature Materials · doi:10.1038/nmat3627 · Cited by 293
Chen, J.-H., & Simmons, C. A. (2011) · Circulation Research · doi:10.1161/circresaha.110.234237 · Cited by 289
Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease
Li, H., & Förstermann, U. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.01.006 · Cited by 285
Kaden, J. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.09.015 · Cited by 285
Kaden, J. J., Dempfle, C.-E., Grobholz, R., Tran, H.-T., Kılıç, R., Sarıkoç, A., Brueckmann, M., Vahl, C., Hagl, S., Haase, K. K., et al. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00284-3 · Cited by 272
RIDKER, P. M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03404.x · Cited by 270
Liu, F., Xia, Y., Parker, A. S., & Verma, I. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01107.x · Cited by 241
Mahler, G. J., Farrar, E. J., & Butcher, J. T. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300504 · Cited by 236
Fondard, O., Detaint, D., Iung, B., Choqueux, C., Adle-Biassette, H., Jarraya, M., Hvass, U., Couetil, J.-P., Henin, D., Michel, J.-B., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi248 · Cited by 235
Induction of local angiotensin II-producing systems in stenotic aortic valves
Helske, S., Lindstedt, K. A., Laine, M., Mäyränpää, M., Werkkala, K., Lommi, J., Turto, H., Kupari, M., & Kovanen, P. T. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.054 · Cited by 221
Inflammation Is Associated with the Remodeling of Calcific Aortic Valve Disease
Coté, N., Mahmut, A., Bosse, Y., Couture, C., Pagé, S., Trahan, S., Boulanger, M.-C., Fournier, D., Pibarot, P., & Mathieu, P. (2013) · Inflammation · doi:10.1007/s10753-012-9579-6 · Cited by 218 · cited 4×
“Of note, the density of neovessels correlates with the presence of chronic inflammatory infiltrates [6].”
BackgroundInfluentialSelf-citationNotch1 represses osteogenic pathways in aortic valve cells
Nigam, V., & Srivastava, D. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.08.008 · Cited by 208
Bosisio, D., Marazzi, I., Agresti, A., Shimizu, N., Bianchi, M. E., & Natoli, G. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600977 · Cited by 202
Chen, J.-H., Chen, W. L. K., Sider, K. L., Yip, C. Y. Y., & Simmons, C. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.220061 · Cited by 189
Jamaluddin, M., Wang, S., Boldogh, I., Tian, B., & Brasier, A. R. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.01.020 · Cited by 185
The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease
Poeckel, D., & Funk, C. D. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq016 · Cited by 185
Mohty, D., Pibarot, P., Després, J.-P., Côté, C., Arsenault, B., Cartier, A., Cosnay, P., Couture, C., & Mathieu, P. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.154989 · Cited by 181 · cited 2×
“To this effect, a high proportion of circulating small, dense, LDL has been associated with a higher accumulation of ox-LDL in the aortic valve and with an elevated level of TNF-α [10].”
BackgroundSelf-citationChondromodulin-I maintains cardiac valvular function by preventing angiogenesis
Yoshioka, M., Yuasa, S., Matsumura, K., Kimura, K., Shiomi, T., Kimura, N., Shukunami, C., Okada, Y., Mukai, M., Shin, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1476 · Cited by 170
Metabolic Syndrome Negatively Influences Disease Progression and Prognosis in Aortic Stenosis
Briand, M., Lemieux, I., Dumesnil, J. G., Mathieu, P., Cartier, A., Després, J.-P., Arsenault, M., Couet, J., & Pibarot, P. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.073 · Cited by 169
Self-citationMcAllister-Lucas, L. M., Ruland, J., Siu, K., Jin, X., Gu, S., Kim, D. S. L., Kuffa, P., Kohrt, D., Mak, T. W., Nuñez, G., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601947103 · Cited by 167
Mechanobiology of the aortic heart valve.
Butcher, J. T., Simmons, C. A., & Warnock, J. N. (2008) · PubMed · Cited by 154
Elevated Expression of Lipoprotein-Associated Phospholipase A2 in Calcific Aortic Valve Disease
Mahmut, A., Boulanger, M., Husseini, D. E., Fournier, D., Bouchareb, R., Després, J., Pîbarot, P., Bossé, Y., & Mathieu, P. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.105 · Cited by 153
Self-citationMazzone, A., Epistolato, M. C., Caterina, R. D., Storti, S., Vittorini, S., Sbrana, S., Gianetti, J., Bevilacqua, S., Glauber, M., Biagini, A., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.041 · Cited by 150
El Husseini, D., Boulanger, M.-C., Mahmut, A., Bouchareb, R., Laflamme, M.-H., Fournier, D., Pibarot, P., Bossé, Y., & Mathieu, P. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.02.014 · Cited by 150 · cited 10×
“Inhibition of BMP2with Noggin, an antagonist of BMP2 and BMP4, prevented IL-6induced mineralization of VICs [23].”
BackgroundInfluentialSelf-citationYu, Z., Seya, K., Daitoku, K., Motomura, S., Fukuda, I., & Furukawa, K. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.177915 · Cited by 145
Arishiro, K., Hoshiga, M., Negoro, N., Jin, D., Takai, S., Miyazaki, M., Ishihara, T., & Hanafusa, T. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.043 · Cited by 143
Lee, H.-L., Woo, K. M., Ryoo, H., & Baek, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.027 · Cited by 143
Kaden, J., Kiliç, R., Sarikoç, A., Hagl, S., Lang, S., Hoffmann, U., Brueckmann, M., & Borggrefe, M. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.16.5.869 · Cited by 130
Côté, C., Pibarot, P., Després, J.-P., Mohty, D., Cartier, A., Arsenault, B. J., Couture, C., & Mathieu, P. (2008) · Heart · doi:10.1136/hrt.2007.125740 · Cited by 121
Self-citationHelske, S., Syväranta, S., Lindstedt, K. A., Lappalainen, J., Öörni, K., Mäyränpää, M. I., Lommi, J., Turto, H., Werkkala, K., Kupari, M., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000228824.01604.63 · Cited by 113
Nagy, E., Andersson, D. C., Caidahl, K., Eriksson, M. J., Eriksson, P., Franco-Cereceda, A., Hansson, G. K., & Bäck, M. (2011) · Circulation · doi:10.1161/circulationaha.110.966846 · Cited by 112
Morrison, M. D., Reiley, W. W., Zhang, M., & Sun, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413634200 · Cited by 110
Galeone, A., Brunetti, G., Oranger, A., Greco, G., Benedetto, A. D., Mori, G., Colucci, S. C., Zallone, A. Z., Paparella, D., & Grano, M. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.09.012 · Cited by 106
Branchetti, E., Sainger, R., Poggio, P., Grau, J. B., Patterson-Fortin, J., Bavaria, J. E., Chorny, M., Lai, E., Gorman, R. C., Levy, R. J., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300177 · Cited by 103
(2005) · PubMed · Cited by 99
Self-citation5-HT2B antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation
Hutcheson, J. D., Ryzhova, L. M., Setola, V., & Merryman, W. D. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.08.012 · Cited by 99
Impact of hypertension and renin–angiotensin system inhibitors in aortic stenosis
Capoulade, R., Clavel, M., Mathieu, P., Côté, N., Dumesnil, J. G., Arsenault, M., Bédard, É., & Pibarot, P. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12169 · Cited by 97 · cited 1×
“Moreover, a retrospective study showed that ARBs are associated with a slower progression rate of aortic stenosis [57].”
BackgroundSelf-citationTreatment With Methotrexate Inhibits Atherogenesis in Cholesterol-Fed Rabbits
Bulgarelli, A., Martins Dias, A. A., Caramelli, B., & Maranhão, R. C. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318241c385 · Cited by 95
ATP acts as a survival signal and prevents the mineralization of aortic valve
Côté, N., El Husseini, D., Pépin, A., Guauque-Olarte, S., Ducharme, V., Bouchard-Cannon, P., Audet, A., Fournier, D., Gaudreault, N., Derbali, H., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.02.003 · Cited by 95 · cited 4×
“InVICs, secretion of ATP gives a survival signal through the P2Y2R and Akt.”
BackgroundInfluentialSelf-citationDistribution of SPARC during neovascularisation of degenerative aortic stenosis
Charest, A., Pépin, A., Shetty, R., Côté, C., Voisine, P., Dagenais, F., Pibarot, P., & Mathieu, P. (2006) · Heart · doi:10.1136/hrt.2005.086595 · Cited by 92
Self-citationHochrainer, K., Racchumi, G., & Anrather, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.385625 · Cited by 91
Song, R., Zeng, Q., Ao, L., Yu, J. A., Cleveland, J. C., Zhao, K.-S., Fullerton, D. A., & Meng, X. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300116 · Cited by 86 · cited 1×
“More recently, biglycan has been shown to promote the osteogenic transition of VICs through TLR-2, the extracellular signal-regulated protein kinase 1/2 (ERK1/2), and the NF-κB pathways [68].”
BackgroundDeficiency of Interleukin-1 Receptor Antagonist Induces Aortic Valve Disease in BALB/c Mice
Isoda, K., Matsuki, T., Kondo, H., Iwakura, Y., & Ohsuzu, F. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.201749 · Cited by 83
Bone formation in cardiac valves: a histopathological study of 128 cases
Steiner, I., Kašparová, P., Kohout, A., & Dominik, J. (2007) · Virchows Archiv · doi:10.1007/s00428-007-0430-7 · Cited by 78 · cited 1×
“Three, in about 15% of mineralized aortic valves osteogenic metaplasia is observed [12].”
BackgroundZeng, Q., Jin, C., Ao, L., Cleveland, J. C., Song, R., Xu, D., Fullerton, D. A., & Meng, X. (2012) · Circulation · doi:10.1161/circulationaha.111.083675 · Cited by 78
Perrotta, I., Russo, E., Camastra, C., Filice, G., Di Mizio, G., Colosimo, F., Ricci, P., Tripepi, S., Amorosi, A., Triumbari, F., et al. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.03977.x · Cited by 77
Bouchareb, R., Boulanger, M., Fournier, D., Pîbarot, P., Messaddeq, Y., & Mathieu, P. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.12.009 · Cited by 77
Self-citationZeng, Q., Song, R., Ao, L., Weyant, M. J., Lee, J., Xu, D., Fullerton, D. A., & Meng, X. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300912 · Cited by 76
Derbali, H., Bossé, Y., Côté, N., Pibarot, P., Audet, A., Pépin, A., Arsenault, B., Couture, C., Després, J.-P., & Mathieu, P. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090541 · Cited by 71
Self-citationWINCHESTER, R. J., Wiesendanger, M., O’Brien, W., Zhang, H.-Z., Maurer, M. S., Gillam, L. D., Schwartz, A. J., Marboe, C. C., & Stewart, A. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003521 · Cited by 70
El Husseini, D., Boulanger, M.-C., Fournier, D., Mahmut, A., Bossé, Y., Pibarot, P., & Mathieu, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053393 · Cited by 62
Self-citationGhosh, C. C., Ramaswami, S., Juvekar, A., Vu, H.-Y. T., Galdieri, L. C., Davidson, D., & Vancurova, I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902230 · Cited by 62
Weiss, R. M., Lund, D. D., Chu, Y., Brooks, R. M., Zimmerman, K. A., Accaoui, R. E., Davis, M. K., Hajj, G. P., Zimmerman, M. B., & Heistad, D. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065201 · Cited by 61
Côté, N., Mahmut, A., Fournier, D., Boulanger, M.-C., Couture, C., Després, J.-P., Trahan, S., Bossé, Y., Pagé, S., Pibarot, P., et al. (2014) · Pathobiology · doi:10.1159/000350896 · Cited by 59
Self-citationFujisaka, T., Hoshiga, M., Hotchi, J., Takeda, Y., Jin, D., Takai, S., Hanafusa, T., & Ishizaka, N. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.055 · Cited by 55 · cited 1×
“In mice, the administration of angiotensin II promoted the fibrotic remodelling of the aortic valve [58].”
BackgroundCôté, N., Pîbarot, P., Pépin, A., Fournier, D., Audet, A., Arsenault, B. J., Couture, C., Poirier, P., Després, J., & Mathieu, P. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.05.054 · Cited by 52
Self-citationMolecular biology of calcific aortic valve disease: towards new pharmacological therapies
Mathieu, P., Boulanger, M.-C., & Bouchareb, R. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.923756 · Cited by 52
Self-citationWu, H. D., Maurer, M. S., Friedman, R. A., Marboe, C. C., Ruiz-Vazquez, E. M., Ramakrishnan, R., Schwartz, A. J., Tilson, M. D., Stewart, A. S., & WINCHESTER, R. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5329 · Cited by 49
Aortic Valve: Turning Over a New Leaf(let) in Endothelial Phenotypic Heterogeneity
Davies, P. F., Passerini, A. G., & Simmons, C. A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000130659.89433.c1 · Cited by 45
Mast Cells in Human Stenotic Aortic Valves Are Associated with the Severity of Stenosis
Wypasek, E., Natorska, J., Grudzień, G., Filip, G., Sadowski, J., & Undas, A. (2013) · Inflammation · doi:10.1007/s10753-012-9565-z · Cited by 44
Côté, N., Husseini, D. E., Pépin, A., Bouvet, C., Gilbert, L.-A., Audet, A., Fournier, D., Pîbarot, P., Moreau, P. R., & Mathieu, P. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.05.016 · Cited by 43
Self-citationNew Therapeutic Targets for Calcific Aortic Valve Stenosis
Hung, M.-Y., Witztum, J. L., & Tsimikas, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1639 · Cited by 42
Lp‐PLA 2 is associated with structural valve degeneration of bioprostheses
Mahmut, A., Mahjoub, H., Boulanger, M., Fournier, D., Després, J., Pibarot, P., & Mathieu, P. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12199 · Cited by 37
Self-citationSong, R., Ao, L., Zhao, K.-S., Zheng, D., Venardos, N., Fullerton, D. A., & Meng, X. (2014) · Inflammation Research · doi:10.1007/s00011-014-0743-3 · Cited by 37
Osman, N., Grande-Allen, K. J., Ballinger, M. L., Getachew, R., Marasco, S., O'Brien, K. D., & Little, P. J. (2013) · Cardiovascular Pathology · doi:10.1016/j.carpath.2012.07.002 · Cited by 32
Lipoprotein lipase in aortic valve stenosis is associated with lipid retention and remodelling
Mahmut, A., Boulanger, M., Fournier, D., Couture, C., Trahan, S., Pagé, S., Arsenault, B., Després, J., Pibarot, P., & Mathieu, P. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12081 · Cited by 31 · cited 2×
“The expression of decorin is increased in aortic valves and histological studies showed a colocalization of decorin with lipoprotein lipase (LPL), which is secreted by macrophages [66].”
BackgroundSelf-citationox-LDL induces PiT-1 expression in human aortic valve interstitial cells
Nadlonek, N. A., Lee, J. H., Weyant, M. J., Meng, X., & Fullerton, D. A. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.05.001 · Cited by 30
Choudhary, S., Lu, M., Cui, R., & Brasier, A. R. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0465 · Cited by 29
Pharmacology of ectonucleotidases: Relevance for the treatment of cardiovascular disorders
Mathieu, P. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.003 · Cited by 16
Self-citationInduction of Human Cytotoxic T Lymphocytes by Oxidized Low Density Lipoproteins
Wu, R., Giscombe, R., Holm, G., & Lefvert, A. (1996) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1996.d01-51.x · Cited by 15
Research works printed but not linked: 3
- 2008, Journal of Heart Valve Disease, 17, 62
- 2005, Journal of Heart Valve Disease, 14, 353
- 2005, International Journal of Molecular Medicine, 16, 869
Cited by
Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.6 · Cited by 982
Self-citationAortic Valve Stenosis: From Basic Mechanisms to Novel Therapeutic Targets
Goody, P. R., Hosen, M. R., Christmann, D., Niepmann, S. T., Zietzer, A., Adam, M., Bönner, F., Zimmer, S., Nickenig, G., & Jansen, F. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313067 · Cited by 331
Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions
Cheung, D. Y., Duan, B., & Butcher, J. T. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1051527 · Cited by 160
Adaptive immune cells in calcific aortic valve disease
Raddatz, M. A., Madhur, M. S., & Merryman, W. D. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00100.2019 · Cited by 91
Qingchun, Z., Song, R., Fullerton, D. A., Ao, L., Zhai, Y., Li, S., Ballak, D. B., Cleveland, J. C., Reece, T. B., McKinsey, T. A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619667114 · Cited by 118
Metadata
- Authors
- Mathieu, P., Bouchareb, R., & Boulanger, M.-C.
- Affiliations
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Corresponding author
- Mathieu, Patrick
- Venue
- Journal of Immunology Research
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-11
- ISSN
- 2314-7156 (ISSN-L)
- 2314-8861
- PMC
- PMC4433691
- OpenAlex
- W1963647443
- Cited by
- 121
- References
- 104
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 8 · 2023: 12 · 2022: 18 · 2021: 15 · 2020: 12 · 2019: 10 · 2018: 7 · 2017: 10 · 2016: 7 · 2015: 1
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Immunology Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Havering Sixth Form College (MOP245048, MOP114893)
- Canadian Institutes of Health Research (MOP245048, MOP114893)
- Quebec Heart and Lung Institute (MOP245048, MOP114893)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- calcific aortic valve disease, innate immunity, adaptive immunity, valvular interstitial cells, NF-κB signaling, TNF-α, interleukin-6, osteogenic differentiation, Toll-like receptors, oxidized lipids, 5-lipoxygenase, leukotrienes, inflammation
- MeSH terms
- Bicuspid Aortic Valve Disease, Animals, Aortic Valve, Aortic Valve Stenosis, Calcinosis, Heart Defects, Congenital, Heart Valve Diseases, Humans, Immunity, Innate, Tumor Necrosis Factor-alpha, Interleukin-6, NF-kappa B, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.